Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

Julia A. Breyer, Raymond P. Bain, Joni K. Evans, N. Stanley Nahman, Edmund J. Lewis, Melisa Cooper, Janet Mcgill, Tomas Berl

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

We designed a prospective, double-blind controlled trial to determine predictors of loss of renal function in patients with insulin dependent diabetes and established nephropathy. A total of 409 insulin-dependent diabetic patients with established nephropathy enrolled in a trial on the effect of Captopril on the rate of progression of renal disease. Baseline demographic, clinical (history and physical) and laboratory parameters were analyzed as risk factors for time to progression. Dichotomous characteristics were compared by Fisher's exact test and continuous characteristics with the Wilcoxon rank-sum test. Univariate proportional hazards regression analysis was used to estimate relative risk of nephropathy progression, and bivariate proportional hazard regression to identify interactions with the treatment group assignment. Multivariate proportional hazard regression was employed to determine which characteristics were independent risk factors. We found that a number of demographic and clinical characteristics were significantly associated with nephropathy progression even after adjustment for treatment group. However, after multivariate analysis, the risk factors that independently predicted progression were onset of IDDM later in life, parental diagnosis of IDDM, the presence of edema, increased mean arterial pressure, and an abnormal electrocardiogram. Likewise, a number of laboratory characteristics were also predictive of nephropathy progression. A low hematocrit, high blood sugar, and higher protein excretion predicted nephropathy progression as did a higher serum creatinine, particularly in the face of a normal serum albumin. In conclusion, this study identifies a number of clinical and laboratory risk factors that can predict which patients with insulin-dependent diabetes with established nephropathy are more likely to sustain a clinically important decrease in renal function over a median follow-up of three years.

Original languageEnglish (US)
Pages (from-to)1651-1658
Number of pages8
JournalKidney International
Volume50
Issue number5
DOIs
StatePublished - Nov 1996

Fingerprint

Diabetic Nephropathies
Renal Insufficiency
Insulin
Nonparametric Statistics
Type 1 Diabetes Mellitus
Kidney
Demography
Captopril
Hematocrit
Serum Albumin
Disease Progression
Blood Glucose
Edema
Creatinine
Arterial Pressure
Electrocardiography
Multivariate Analysis
History
Regression Analysis
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. / Breyer, Julia A.; Bain, Raymond P.; Evans, Joni K.; Nahman, N. Stanley; Lewis, Edmund J.; Cooper, Melisa; Mcgill, Janet; Berl, Tomas.

In: Kidney International, Vol. 50, No. 5, 11.1996, p. 1651-1658.

Research output: Contribution to journalArticle

Breyer, Julia A. ; Bain, Raymond P. ; Evans, Joni K. ; Nahman, N. Stanley ; Lewis, Edmund J. ; Cooper, Melisa ; Mcgill, Janet ; Berl, Tomas. / Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. In: Kidney International. 1996 ; Vol. 50, No. 5. pp. 1651-1658.
@article{9a0e70eb22844bab8d260c45d00bbf87,
title = "Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy",
abstract = "We designed a prospective, double-blind controlled trial to determine predictors of loss of renal function in patients with insulin dependent diabetes and established nephropathy. A total of 409 insulin-dependent diabetic patients with established nephropathy enrolled in a trial on the effect of Captopril on the rate of progression of renal disease. Baseline demographic, clinical (history and physical) and laboratory parameters were analyzed as risk factors for time to progression. Dichotomous characteristics were compared by Fisher's exact test and continuous characteristics with the Wilcoxon rank-sum test. Univariate proportional hazards regression analysis was used to estimate relative risk of nephropathy progression, and bivariate proportional hazard regression to identify interactions with the treatment group assignment. Multivariate proportional hazard regression was employed to determine which characteristics were independent risk factors. We found that a number of demographic and clinical characteristics were significantly associated with nephropathy progression even after adjustment for treatment group. However, after multivariate analysis, the risk factors that independently predicted progression were onset of IDDM later in life, parental diagnosis of IDDM, the presence of edema, increased mean arterial pressure, and an abnormal electrocardiogram. Likewise, a number of laboratory characteristics were also predictive of nephropathy progression. A low hematocrit, high blood sugar, and higher protein excretion predicted nephropathy progression as did a higher serum creatinine, particularly in the face of a normal serum albumin. In conclusion, this study identifies a number of clinical and laboratory risk factors that can predict which patients with insulin-dependent diabetes with established nephropathy are more likely to sustain a clinically important decrease in renal function over a median follow-up of three years.",
author = "Breyer, {Julia A.} and Bain, {Raymond P.} and Evans, {Joni K.} and Nahman, {N. Stanley} and Lewis, {Edmund J.} and Melisa Cooper and Janet Mcgill and Tomas Berl",
year = "1996",
month = "11",
doi = "10.1038/ki.1996.481",
language = "English (US)",
volume = "50",
pages = "1651--1658",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

AU - Breyer, Julia A.

AU - Bain, Raymond P.

AU - Evans, Joni K.

AU - Nahman, N. Stanley

AU - Lewis, Edmund J.

AU - Cooper, Melisa

AU - Mcgill, Janet

AU - Berl, Tomas

PY - 1996/11

Y1 - 1996/11

N2 - We designed a prospective, double-blind controlled trial to determine predictors of loss of renal function in patients with insulin dependent diabetes and established nephropathy. A total of 409 insulin-dependent diabetic patients with established nephropathy enrolled in a trial on the effect of Captopril on the rate of progression of renal disease. Baseline demographic, clinical (history and physical) and laboratory parameters were analyzed as risk factors for time to progression. Dichotomous characteristics were compared by Fisher's exact test and continuous characteristics with the Wilcoxon rank-sum test. Univariate proportional hazards regression analysis was used to estimate relative risk of nephropathy progression, and bivariate proportional hazard regression to identify interactions with the treatment group assignment. Multivariate proportional hazard regression was employed to determine which characteristics were independent risk factors. We found that a number of demographic and clinical characteristics were significantly associated with nephropathy progression even after adjustment for treatment group. However, after multivariate analysis, the risk factors that independently predicted progression were onset of IDDM later in life, parental diagnosis of IDDM, the presence of edema, increased mean arterial pressure, and an abnormal electrocardiogram. Likewise, a number of laboratory characteristics were also predictive of nephropathy progression. A low hematocrit, high blood sugar, and higher protein excretion predicted nephropathy progression as did a higher serum creatinine, particularly in the face of a normal serum albumin. In conclusion, this study identifies a number of clinical and laboratory risk factors that can predict which patients with insulin-dependent diabetes with established nephropathy are more likely to sustain a clinically important decrease in renal function over a median follow-up of three years.

AB - We designed a prospective, double-blind controlled trial to determine predictors of loss of renal function in patients with insulin dependent diabetes and established nephropathy. A total of 409 insulin-dependent diabetic patients with established nephropathy enrolled in a trial on the effect of Captopril on the rate of progression of renal disease. Baseline demographic, clinical (history and physical) and laboratory parameters were analyzed as risk factors for time to progression. Dichotomous characteristics were compared by Fisher's exact test and continuous characteristics with the Wilcoxon rank-sum test. Univariate proportional hazards regression analysis was used to estimate relative risk of nephropathy progression, and bivariate proportional hazard regression to identify interactions with the treatment group assignment. Multivariate proportional hazard regression was employed to determine which characteristics were independent risk factors. We found that a number of demographic and clinical characteristics were significantly associated with nephropathy progression even after adjustment for treatment group. However, after multivariate analysis, the risk factors that independently predicted progression were onset of IDDM later in life, parental diagnosis of IDDM, the presence of edema, increased mean arterial pressure, and an abnormal electrocardiogram. Likewise, a number of laboratory characteristics were also predictive of nephropathy progression. A low hematocrit, high blood sugar, and higher protein excretion predicted nephropathy progression as did a higher serum creatinine, particularly in the face of a normal serum albumin. In conclusion, this study identifies a number of clinical and laboratory risk factors that can predict which patients with insulin-dependent diabetes with established nephropathy are more likely to sustain a clinically important decrease in renal function over a median follow-up of three years.

UR - http://www.scopus.com/inward/record.url?scp=19244364808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244364808&partnerID=8YFLogxK

U2 - 10.1038/ki.1996.481

DO - 10.1038/ki.1996.481

M3 - Article

C2 - 8914032

AN - SCOPUS:19244364808

VL - 50

SP - 1651

EP - 1658

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -